JPS54106402A - Amylase inhibitor tai-a - Google Patents
Amylase inhibitor tai-aInfo
- Publication number
- JPS54106402A JPS54106402A JP1440778A JP1440778A JPS54106402A JP S54106402 A JPS54106402 A JP S54106402A JP 1440778 A JP1440778 A JP 1440778A JP 1440778 A JP1440778 A JP 1440778A JP S54106402 A JPS54106402 A JP S54106402A
- Authority
- JP
- Japan
- Prior art keywords
- tai
- reaction
- amylase
- inhibitor
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940122816 Amylase inhibitor Drugs 0.000 title abstract 2
- 239000003392 amylase inhibitor Substances 0.000 title abstract 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000004382 Amylase Substances 0.000 abstract 1
- 102000013142 Amylases Human genes 0.000 abstract 1
- 108010065511 Amylases Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 241000958264 Streptomyces calvus Species 0.000 abstract 1
- 235000019418 amylase Nutrition 0.000 abstract 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000921 elemental analysis Methods 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
NEW MATERIAL:Anylase inhibitor TAI-A. Elemental analysis: C 41.44%, H 6.27%, N 1.32%, O 46.32%; molecular weight: 950W1050; [α]23D: +157.3° (c=0.5%, water); solubility; soluble in water and DMSO, insoluble in methanol, ethanol, etc.; color reaction: positive to Molisch's reaction and anthrone reaction; pKa: 4.2 (in an aqueous solution), basic; appearance: white powder.
USE: Amylase inhibitor. Effective to obesity, hyperlipemia, diabetes, a gastric ulcer, etc. because said substance inhibits the activity of amylase and suppresses the amount of glucose in blood.
PROCESS: Streptomyces calvus var. TM-521 (FERM-P No.4283) belonging to Streptomyces genus, is cultured under aerobic conditions, to obtain TAI-A.
COPYRIGHT: (C)1979,JPO&Japio
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1440778A JPS54106402A (en) | 1978-02-10 | 1978-02-10 | Amylase inhibitor tai-a |
GB7902373A GB2016497A (en) | 1978-02-10 | 1979-01-23 | Microbiological production of amylase inhibitor |
DE19792903710 DE2903710A1 (en) | 1978-02-10 | 1979-01-31 | NEW AMYLASE INHIBITORS AND METHOD FOR THE PRODUCTION THEREOF |
FR7902795A FR2416949A1 (en) | 1978-02-10 | 1979-02-02 | PROCESS FOR THE PREPARATION OF AMYLASE INHIBITORS, NEW PRODUCTS THUS OBTAINED AND THEIR PHARMACEUTICAL USES, ESPECIALLY FOR FIGHTING OBESITY AND HYPERGLYCEMIA |
US06/009,157 US4197292A (en) | 1978-02-10 | 1979-02-02 | Novel amylase inhibitors |
CH114079A CH637542A5 (en) | 1978-02-10 | 1979-02-06 | PROCESS FOR THE PREPARATION OF AMYLASE INHIBITORS, PRODUCTS THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
BE0/193352A BE874037A (en) | 1978-02-10 | 1979-02-08 | PROCESS FOR PREPARING AMYLASE INHIBITORS, NEW PRODUCTS THUS OBTAINED AND THEIR PHARMACEUTICAL USES, ESPECIALLY FOR COMBATTING OBESITY AND HYPERGLYCEMIA |
IT47956/79A IT1114532B (en) | 1978-02-10 | 1979-02-09 | IMPROVEMENT IN AMYLASE INHIBITIVE COMPOSITIONS AND PREPARATION PROCEDURE |
CA321,167A CA1131146A (en) | 1978-02-10 | 1979-02-09 | Amylase inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1440778A JPS54106402A (en) | 1978-02-10 | 1978-02-10 | Amylase inhibitor tai-a |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS54106402A true JPS54106402A (en) | 1979-08-21 |
Family
ID=11860187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1440778A Pending JPS54106402A (en) | 1978-02-10 | 1978-02-10 | Amylase inhibitor tai-a |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS54106402A (en) |
BE (1) | BE874037A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5846013A (en) * | 1981-09-01 | 1983-03-17 | バイエル・アクチエンゲゼルシヤフト | Novel drug preparation of glycoside hydrolase inhibitor |
EP0209118A2 (en) | 1985-07-17 | 1987-01-21 | Konica Corporation | Silver halide photographic material |
-
1978
- 1978-02-10 JP JP1440778A patent/JPS54106402A/en active Pending
-
1979
- 1979-02-08 BE BE0/193352A patent/BE874037A/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5846013A (en) * | 1981-09-01 | 1983-03-17 | バイエル・アクチエンゲゼルシヤフト | Novel drug preparation of glycoside hydrolase inhibitor |
EP0209118A2 (en) | 1985-07-17 | 1987-01-21 | Konica Corporation | Silver halide photographic material |
Also Published As
Publication number | Publication date |
---|---|
BE874037A (en) | 1979-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5452793A (en) | Preparation of formed article | |
EP0476574A3 (en) | Process for manufacturing water adsorbing material and its use in sanitary articles and in soil amelioration | |
JPS568320A (en) | Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent | |
AU528098B2 (en) | Analgesic tablet | |
JPS54106402A (en) | Amylase inhibitor tai-a | |
JPS57136596A (en) | Carcinostatic substance tf-240, its preparation, and carcinostatic agent containing the same | |
JPS54106403A (en) | Amylase inhibitor tai-b | |
JPS5414950A (en) | Preparation of alpha-tetralone | |
JPS57139088A (en) | Carcinostatic substance tf-340, its preparation and carcinostatic agent containing the same | |
JPS57139089A (en) | Carcinostatic substance tf-350, its preparation and carcinostatic agent containing the same | |
JPS53130602A (en) | New antibiotic aculeacin aalpha and its preparation | |
JPS5344692A (en) | Preparation of 2,3,-cyclic nucleotide by fermentation process | |
JPS5625166A (en) | 5-fluorouracil derivative | |
JPS5492697A (en) | Enzyme inhibiting substance m-96 | |
JPS57139090A (en) | Carcinostatic substance tv-110, its preparation and carcinostatic agent containing the same | |
JPS5653101A (en) | Polysaccharide ks-2-d and its preparation | |
JPS5423191A (en) | Preparation of cholin-oxydase by fermentation | |
JPS52136995A (en) | Novel antibiotics sf-1919 and method of preparing the same | |
JPS55130993A (en) | Factor for controlling growth of mycelia and its preparation | |
JPS57140794A (en) | Sen-143 substance and its preparation | |
JPS57139091A (en) | Carcinostatic substance tv-130, its preparation and carcinostatic agent containing the same | |
JPS5661399A (en) | Novel substance th69e and drug containing the same | |
JPS5435280A (en) | Preparation of yeast cells | |
JPS5682097A (en) | Production of glucose | |
JPS568664A (en) | Powdered sweet sake |